Mallinckrodt Settles U.S. Opioid Drug Probe for $35 Mln Mallinckrodt Settles U.S. Opioid Drug Probe for $35 Mln

Mallinckrodt Plc, one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that it failed to report suspicious drug orders, the U.S. Justice Department said on Tuesday.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news